Nutraplus India Ltd

Nutraplus India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nutraplus India Ltd

₹ 2.10 5.00%
13 Dec 2021
nutraplusindia.com
About

Nutraplus India is engaged in the Business of Drugs and Pharmaceuticals.

[ add key points ]
Website
  • Market Cap ₹ 7.16 Cr.
  • Current Price ₹ 2.10
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -1.67
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 5.00
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.01 0.08 0.01 0.12 0.03 0.02 0.00 0.00 0.02 0.03 0.01 0.46 0.02
Operating Profit -0.01 -0.08 -0.01 -0.12 -0.03 -0.02 0.00 0.00 -0.02 -0.03 -0.01 -0.46 -0.02
OPM %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.00
Interest 0.00 0.03 0.00 0.03 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.01 -0.11 -0.01 -0.15 -0.03 -0.02 0.00 0.00 -0.02 -0.02 -0.01 -0.36 -0.02
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.01 -0.11 -0.01 -0.15 -0.03 -0.02 0.00 0.00 -0.02 -0.02 -0.01 -0.36 -0.02
EPS in Rs -0.00 -0.03 -0.00 -0.04 -0.01 -0.01 0.00 0.00 -0.01 -0.01 -0.00 -0.11 -0.01
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
61.56 65.00 77.51 91.05 109.14 139.55 106.67 0.02 0.10 -0.06 0.00 0.00 0.00
51.37 61.79 65.37 92.78 99.83 126.89 142.44 0.38 3.75 0.07 0.06 0.05 0.52
Operating Profit 10.19 3.21 12.14 -1.73 9.31 12.66 -35.77 -0.36 -3.65 -0.13 -0.06 -0.05 -0.52
OPM % 16.55% 4.94% 15.66% -1.90% 8.53% 9.07% -33.53% -1,800.00% -3,650.00%
0.10 -2.94 1.48 0.99 0.12 1.58 0.08 -23.36 0.62 0.00 0.00 0.00 0.10
Interest 3.57 4.52 4.86 5.01 4.67 6.85 7.43 0.80 0.00 0.03 0.00 0.00 -0.01
Depreciation 1.61 1.40 1.72 2.21 3.88 4.03 4.70 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 5.11 -5.65 7.04 -7.96 0.88 3.36 -47.82 -24.52 -3.03 -0.16 -0.06 -0.05 -0.41
Tax % 38.75% -28.14% -12.64% -21.36% 84.09% 34.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
3.13 -4.06 7.93 -6.26 0.14 2.19 -47.83 -24.52 -3.03 -0.16 -0.06 -0.05 -0.41
EPS in Rs 2.41 -1.66 2.85 -1.84 0.04 0.64 -14.03 -7.19 -0.89 -0.05 -0.02 -0.01 -0.13
Dividend Payout % 0.00% 0.00% 7.99% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: 7%
5 Years: 15%
3 Years: 26%
TTM: -925%
Stock Price CAGR
10 Years: -31%
5 Years: -6%
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 5.90 11.16 12.67 17.05 17.05 17.05 17.05 17.05 17.05 17.05 17.05 17.05 17.05
Reserves 14.35 36.01 50.22 50.17 50.19 52.40 4.57 -19.10 -22.13 -22.28 -22.35 -22.40 -22.76
31.55 40.29 72.05 65.77 73.38 74.93 75.88 1.75 1.75 1.76 1.78 1.79 2.23
23.44 26.60 30.66 37.27 31.21 25.32 39.37 34.99 12.28 8.72 8.77 8.73 8.48
Total Liabilities 75.24 114.06 165.60 170.26 171.83 169.70 136.87 34.69 8.95 5.25 5.25 5.17 5.00
35.67 22.95 32.89 38.64 72.31 82.44 81.19 0.00 0.00 0.00 0.00 0.00 0.00
CWIP 1.04 13.42 37.53 48.27 21.59 17.26 12.67 0.12 0.00 0.00 0.00 0.00 0.00
Investments 0.05 4.20 4.15 4.16 4.15 4.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15
38.48 73.49 91.03 79.19 73.78 65.85 42.86 34.42 8.80 5.10 5.10 5.02 4.85
Total Assets 75.24 114.06 165.60 170.26 171.83 169.70 136.87 34.69 8.95 5.25 5.25 5.17 5.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3.98 -16.49 -9.61 19.66 6.69 12.36 9.07 -14.25 -0.15 0.02 -0.01 0.00
-10.82 -5.10 -34.42 -18.59 -10.70 -9.74 -2.69 93.77 0.12 0.00 0.00 0.00
6.80 31.53 35.54 -1.91 4.00 -2.66 -7.57 -80.25 0.00 -0.03 0.02 0.00
Net Cash Flow -0.04 9.94 -8.48 -0.84 -0.01 -0.03 -1.18 -0.73 -0.03 -0.01 0.01 0.00
Free Cash Flow -6.89 -37.12 -45.37 0.96 -4.13 2.50 6.24 79.49 -0.03 0.02 -0.01 0.00
CFO/OP 26% -514% -72% -1,139% 80% 103% -26% 3,958% 4% -15% 17% 0%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 87.57 75.13 119.80 104.79 83.71 42.97 9.48 19,710.00 1,898.00 -2,676.67
Inventory Days 169.68 134.40 181.03 113.18 110.73 124.02 89.78 363.97 0.00
Days Payable 168.01 186.44 189.62 177.37 132.71 75.89 35.11 878.67
Cash Conversion Cycle 89.25 23.09 111.21 40.60 61.73 91.10 64.15 19,710.00 1,383.31 -2,676.67
Working Capital Days -1.30 60.53 117.30 20.61 28.43 1.99 -160.65 447,855.00 0.00 -22,386.67
ROCE % 19.22% 2.89% 9.65% -2.85% 4.06% 8.78% -33.35% -0.56%

Insights

In beta
Sep 2016 Mar 2020 Jun 2025
Number of Manufacturing Units
Number

Log in to view insights

Please log in to see hidden values.

Login

Shareholding Pattern

Numbers in percentages

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07%
0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
59.91% 59.91% 59.91% 59.91% 59.91% 59.90% 59.90% 59.90% 59.91% 59.90% 59.91% 59.91%
No. of Shareholders 8,0887,8787,8427,8167,8287,8437,8117,8057,8177,7507,7247,943

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Annual reports

Credit ratings

Concalls

  • Sep 2016
    Transcript
    AI Summary
    PPT